MARTINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.113
EU - Europa 307
AS - Asia 208
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 1.632
Nazione #
US - Stati Uniti d'America 1.112
IT - Italia 177
CN - Cina 86
SG - Singapore 80
FI - Finlandia 21
GB - Regno Unito 21
VN - Vietnam 18
SE - Svezia 17
DE - Germania 15
FR - Francia 13
IN - India 13
NL - Olanda 13
RU - Federazione Russa 13
HK - Hong Kong 6
AT - Austria 3
CZ - Repubblica Ceca 3
MK - Macedonia 3
IE - Irlanda 2
RO - Romania 2
TR - Turchia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
EU - Europa 1
HU - Ungheria 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
SC - Seychelles 1
Totale 1.632
Città #
Fairfield 190
Woodbridge 129
Chandler 103
Ashburn 80
Cambridge 67
Houston 61
Seattle 59
Singapore 58
Ann Arbor 49
Wilmington 49
Santa Clara 39
Padova 35
Boardman 34
San Diego 28
Dong Ket 18
Medford 17
Princeton 17
Guangzhou 16
Milan 14
Des Moines 13
Rome 12
Helsinki 10
Beijing 8
Dearborn 8
Roxbury 8
Shanghai 8
Hong Kong 6
Kunming 6
Nanjing 6
Riese Pio X 6
Jacksonville 5
London 5
Naples 5
Shenyang 5
Jinan 4
Pune 4
Brno 3
Catania 3
Nuremberg 3
Phoenix 3
Skopje 3
Bhopal 2
Bussero 2
Dallas 2
Dublin 2
Falkenstein 2
Florence 2
Fossò 2
Genoa 2
Gurugram 2
Hebei 2
Hounslow 2
Hyderabad 2
Inveruno 2
Istanbul 2
Lana 2
Lappeenranta 2
Mariano Comense 2
Matera 2
Mestre 2
Mineo 2
Nanchang 2
New York 2
Nocera Superiore 2
Palermo 2
Podenzana 2
Prescot 2
Recco 2
Somma Vesuviana 2
Taormina 2
Trento 2
Umbertide 2
Viagrande 2
Villafranca Padovana 2
Zhengzhou 2
Amsterdam 1
Belgrade 1
Biella 1
Borås 1
Brisbane 1
Budapest 1
Cerea 1
Chengdu 1
Chiswick 1
Fuzhou 1
Garbagnate Milanese 1
Grottammare 1
Haikou 1
Handan 1
Jakubowizna 1
Limbiate 1
Messina 1
Mexico City 1
Modena 1
Munich 1
New Bedfont 1
New Delhi 1
Novara 1
Ogden 1
Orange 1
Totale 1.290
Nome #
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 118
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 115
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 102
Tocilizumab for severe COVID-19 pneumonia 99
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 97
Occult liver disease burden: Analysis from a large general practitioners’ database 92
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 89
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 87
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 85
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C 83
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma 82
Liver pro-oncogenic potential of SERPINB3. 82
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 79
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 76
null 64
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients 63
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 55
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 54
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 47
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 32
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 22
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 17
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 12
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 10
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma 5
SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives 5
Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma 4
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases 3
Natural history of acute kidney disease in patients with cirrhosis 1
Totale 1.680
Categoria #
all - tutte 7.844
article - articoli 7.455
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 389
Totale 15.688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 0 0 27 22 22 13 4
2020/2021243 8 10 46 5 2 10 4 16 30 56 13 43
2021/2022278 29 49 12 12 17 24 23 12 10 17 19 54
2022/2023196 38 22 8 20 29 22 1 16 27 2 8 3
2023/2024200 3 22 23 20 17 19 20 12 9 14 15 26
2024/2025362 12 70 52 53 69 26 65 15 0 0 0 0
Totale 1.680